Vivek Ramaswamy’s crusade to change FDA could boost biotech, and himself

The co-leader of President-elect Donald Trump’s initiative to cut government spending has a financial stake in the biotech firm he founded, which is developing experimental drugs.

washingtonpost.com

Read full article on: washingtonpost.com

unread news